The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose, the companies said Thursday.
It's the first look at how long protection for a coronavirus vaccine lasts, and while six months is a modest target, it's longer than the 90 days of protection been the best estimate offered to date.
The vaccine remains more than 91% effective against disease with any symptoms for six months, the companies said. And it appeared to be fully effective against the worrying B.1.351 variant of the virus, which is the dominant strain circulating in South Africa and which researchers feared had evolved to evade the protection of vaccines, the companies said. Read more:
Here's an update on all developments. Scroll or swipe further for in-depth coverage.
- The company at the center of quality problems that led Johnson & Johnson to discard an unknown amount of its coronavirus vaccine has a string of citations from U.S. health officials for quality control problems.
- Japan designated Osaka and two other areas for new virus control steps on Thursday as infections there rise less than four months before the Tokyo Olympics.
- Former Alaska Gov. Sarah Palin says she tested positive for COVID-19 and is urging people to take steps to guard against the coronavirus, such as wearing masks in public.
- Even with some limitations that exclude drinking at a bar, a lot of activities Californians haven’t been able to enjoy for most of the past year are suddenly within reach as the state reopens more widely.
- Seeking to overcome vaccine hesitancy, the Biden administration is unveiling a coalition of community, religious and celebrity partners to promote COVID-19 shots.
- President Joe Biden told ESPN on Wednesday it was a mistake for the Texas Rangers to allow full capacity at their ballpark for their first game.
For more summaries and full reports, please select from the articles below. Scroll further for the latest virus numbers.